266 related articles for article (PubMed ID: 11945115)
1. Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence.
Jeffcoate W
Drug Saf; 2002; 25(3):199-212. PubMed ID: 11945115
[TBL] [Abstract][Full Text] [Related]
2. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
[TBL] [Abstract][Full Text] [Related]
3. Effect of growth hormone (GH) on fasting and postprandial metabolism in GH deficiency.
Trepp R; Stettler C; Diem P; Christ ER
Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):596-601. PubMed ID: 20146168
[TBL] [Abstract][Full Text] [Related]
4. [Long term treatment with growth hormone deficiency in adults].
Cabo D; Lecube A; Barrios M; Mesa J
Med Clin (Barc); 2011 May; 136(15):659-64. PubMed ID: 21411111
[TBL] [Abstract][Full Text] [Related]
5. Metabolic implications of growth hormone therapy.
Perrini S; Carreira MC; Conserva A; Laviola L; Giorgino F
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):79-84. PubMed ID: 19020393
[TBL] [Abstract][Full Text] [Related]
6. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
[TBL] [Abstract][Full Text] [Related]
7. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
[TBL] [Abstract][Full Text] [Related]
8. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
McConnell EM; Atkinson AB; Ennis C; Hadden DR; McCance DR; Sheridan B; Bell PM
J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703
[TBL] [Abstract][Full Text] [Related]
9. Long-term experience with GH replacement therapy: efficacy and safety.
Monson JP
Eur J Endocrinol; 2003 Apr; 148 Suppl 2():S9-14. PubMed ID: 12670295
[TBL] [Abstract][Full Text] [Related]
10. Reduction in insulin sensitivity and inadequate β-cell capacity to counteract the increase in insulin resistance in children with idiopathic growth hormone deficiency during 12 months of growth hormone treatment.
Ciresi A; Amato MC; Giordano C
J Endocrinol Invest; 2015 Mar; 38(3):351-9. PubMed ID: 25273336
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
Stewart PM; Toogood AA; Tomlinson JW
Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
[TBL] [Abstract][Full Text] [Related]
12. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
14. Postprandial triglyceride profile after a standardized oral fat load is altered in growth hormone (GH)-deficient adult patients and is not improved after short-term GH replacement therapy.
Perotti M; Caumo A; Brunani A; Cambiaghi N; Casati M; Scacchi M; Perra S; Rocco C; Mancia G; Grassi G; Cavagnini F; Pincelli AI
Clin Endocrinol (Oxf); 2012 Nov; 77(5):721-7. PubMed ID: 22519803
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults.
Krusenstjerna-Hafstrøm T; Clasen BF; Møller N; Jessen N; Pedersen SB; Christiansen JS; Jørgensen JO
J Clin Endocrinol Metab; 2011 Aug; 96(8):2548-57. PubMed ID: 21613350
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update.
Gazzaruso C; Gola M; Karamouzis I; Giubbini R; Giustina A
J Clin Endocrinol Metab; 2014 Jan; 99(1):18-29. PubMed ID: 24217903
[TBL] [Abstract][Full Text] [Related]
17. Metabolic consequences of growth hormone treatment in paediatric practice.
Saenger P
Horm Res; 2000; 53 Suppl 1():60-9. PubMed ID: 10895045
[TBL] [Abstract][Full Text] [Related]
18. Insulin sensitivity in adults with growth hormone deficiency and effect of growth hormone treatment.
Groop L; Segerlantz M; Bramnert M
Horm Res; 2005; 64 Suppl 3():45-50. PubMed ID: 16439844
[TBL] [Abstract][Full Text] [Related]
19. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
Lo JC; Mulligan K; Noor MA; Schwarz JM; Halvorsen RA; Grunfeld C; Schambelan M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3480-7. PubMed ID: 11502767
[TBL] [Abstract][Full Text] [Related]
20. Reviewing the safety of GH replacement therapy in adults.
Stochholm K; Johannsson G
Growth Horm IGF Res; 2015 Aug; 25(4):149-57. PubMed ID: 26117668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
